You are in:Home/Publications/Study of some toxic effects of anticancer drug, doxorubicin and the use of some protective agents against doxorubicin induced toxicity (Expermintal study)

Dr. Safwa Mahmoud Soror :: Publications:

Title:
Study of some toxic effects of anticancer drug, doxorubicin and the use of some protective agents against doxorubicin induced toxicity (Expermintal study)
Authors: Safwa Mahmoud sorour
Year: 2014
Keywords: Not Available
Journal: Not Available
Volume: Not Available
Issue: Not Available
Pages: Not Available
Publisher: Not Available
Local/International: International
Paper Link: Not Available
Full paper Safwa Mahmoud Soror_merge.pdf
Supplementary materials Not Available
Abstract:

Doxorubicin is a widely used anthracycline antibiotic in cancer chemotherapy, the most serious adverse effect being life-threatening heart damage. It is commonly used in the treatment of a wide range of cancers, including some leukemias and Hodgkin's lymphoma, as well as cancers of the bladder, breast, stomach, lung, ovaries, thyroid, soft tissue sarcoma, multiple myeloma, and others . Commonly used doxorubicincontaining regimens are AC (Adriamycin, cyclophosphamide), TAC (Taxotere, AC), ABVD (Adriamycin, bleomycin, vinblastine, dacarbazine), and FAC (5-fluorouracil, adriamycin, cyclophosphamide) . Nebivolol is a β1 receptor blocker with nitric oxide-potentiating vasodilator effect used in treatment of hypertension and, also for left ventricular failure . L-Carnitine is a natural substance that helps the body turn fat into energy. Our body makes it in the liver and kidneys and stores it in the skeletal muscles, heart, brain, and sperm. Usually, our body can make all the carnitine it needs. Some people, however, may not have enough carnitine because their bodies cannot make enough or can’t transport it into tissues so it can be used . The present study was carried out to find out and compare the protective effects of nebivolol and L-carnitine against doxorubicin cardiotoxicity , hepatotoxicity and nephrotoxicity, also the in vitro studies were done to investigate the effect of doxorubicin on contractility of isolated normal mammalian heart and the effect of increasing doses of isopernaline on contractility of hearts taken from another 5 groups of rats given the same medications as the groups of the in-vivo experiment. Summary and Conclusion 11 9 Rats were randomly divided into 5 groups (6 rats for each group). control group received saline intraperitoneal in comparative volume to the tested groups, Dox group received doxorubicin intraperitoneally every other day for 12 days, Dox + Neb group received doxorubicin intraperitoneally every other day for 12 days and nebivolol orally daily for 12 days , Dox +L-car group received doxorubicin intraperitoneally every other day for 12 days and L-Carnitine intraperitonially daily for 12 days and Dox + Neb +L-car group received doxorubicin intraperitoneally every other day for 12 days nebivolol orally and L-Carnitine intraperitonially daily for 12 days. At the end of the study period, ECG, blood pressure, troponin I ,CPK, creatinine ,ALT, AST were measured and histopathololgical examination of heart , liver and kidney was done . It was found that doxorubicin administration caused significant increase in T wave voltage, significant reduction in blood pressure and significant elevation in troponin I ,CPK, ALT, AST, creatinine serum levels and prominent histopathological changes compared to control group . This study revealed that nebivolol and L-carnitine produced a significant reduction in T wave voltage, significant elevation in blood pressure and significant reduction in troponin I ,CPK, , ALT, AST, creatinine serum levels and improved markedly histopathological changes compared to Dox group . Comparing the result of Dox+Neb +L- car group with that of Dox+ neb group and Dox + L-car group, adding L-carnitine to nebivolol was not significantly more effective than nebivolol or L-carnitine alone in reducing T wave voltage . Comparing the result of Dox +Neb+L- car group with that of Dox+ neb group, adding L-carnitine to nebivolol was significantly more effective than nebivolol alone in elevating systolic & mean blood Summary and Conclusion 12 0 pressure and comparing the result of Dox+Neb+L- car group with that of Dox + L-car group, adding nebivolol to L- carnitine was not significantly more effective than nebivolol alone in elevating systolic blood pressure & mean blood pressure also was found that comparing the result of Dox+Neb+L- car group with that of Dox+Neb group and Dox + L-car group adding L-carnitine to nebivolol was not significantly more effective than nebivolol or L- carnitine alone in reducing the cardiac enzymes. Comparing the result of Dox +Neb + L_Car group with that of Dox + Neb group and Dox + L-car group, adding nebivolol to L- carnitine was not significantly more effective than nebivolol alone in reducing the liver enzymes. Comparing the result of Dox+Neb + L- car group with that of Dox + Neb group and Dox + L-car group, adding L-carnitine to nebivolol was not significantly more effective than nebivolol alone in reducing the creatinine level . In-vitro study, It was noticed that isoprenaline in increasing doses (2, 4 and 8 μg/bath) produced an increase in the force of spontaneous contraction of isolated perfused rat’s heart in dose related manner. In Dox group it was noticed that isoprenaline in increasing doses (2 , 4 μg/bath) produced an non significant increase in the force of spontaneous contraction of isolated perfused rabbit’s heart .This increase of the force of spontaneous contractions of the isolated perfused rabbit’s heart was significant with the dose of 8μg/bath. with percentage of increase 59.1 % compared to preisoprenaline contraction In Dox + Neb group it was noticed that isoprenaline in increasing doses (4 and 8 μg/bath) produced an increase in the force of spontaneous contraction of isolated perfused rat’s heart in dose related manner. This increase of the force of spontaneous contractions of the isolated perfused rat’s heart was not significant with the dose of 2μg/bath. Summary and Conclusion 12 1 In Dox + L-car group it was noticed that isoprenaline in increasing doses (4 and 8 μg/bath) produced an increase in the force of spontaneous contraction of isolated perfused rabbit’s heart in dose related manner. This increase of the force of spontaneous contractions of the isolated perfused rabbit’s heart was not significant (P > 0.05) with the dose of 2μg/bath . In Dox + Neb +L- car group it was noticed that isoprenaline in increasing doses (2 , 4 and 8 μg/bath) produced an increase in the force of spontaneous contraction of isolated perfused rat’s heart in dose related manner. It was noticed that doxorubicin in a gradually increasing doses (1/2 , 1, 2 and 4 μg / bath) produced a decrease in the force of spontaneous contraction of isolated perfused rabbit’s heart in dose related manner. Also it was noticed that doxorubicin decrease the positive inotropic effect of isoprenaline in a dose of 2 μg / bath on isolated perfused rabbit’s heart . In conclusion, doxorubicin can induce cardiotoxicity, hepatotoxicity and nephrotoxicity which can be ameliorated by using nebivolol and L-carnitine which are effective and may be recommended for protection against doxorubicin cardiotoxicity, hepatotoxicity and nephrotoxicity .

Google ScholarAcdemia.eduResearch GateLinkedinFacebookTwitterGoogle PlusYoutubeWordpressInstagramMendeleyZoteroEvernoteORCIDScopus